Gilead’s Viread to be covered by health insurance

Published: 2012-09-19 06:59:00

Updated: 2012-09-19 06:59:00

The National Health Insurance Corporation (NHIC) said Monday that it would list Gilead Sciences’ Viread (tenofovir) into the positive list from November, as the US based company’s Korean exclusive distributor Yuhan Corp. finally agreed to reduce the insurance price of Viread below the average wei...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK